Monimus Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$423K Hold
146,284
0.31% 48
2025
Q1
$315K Buy
146,284
+99,184
+211% +$213K 0.27% 45
2024
Q4
$182K Buy
+47,100
New +$182K 0.17% 50